Jci_page_head_homepage_01 Jci_page_head_homepage_02
Laure Michel, Laureline Berthelot, Ségolène Pettré, Sandrine Wiertlewski, Fabienne Lefrère, Cécile Braudeau, Sophie Brouard, Jean-Paul Soulillou, David-Axel Laplaud
Published in Volume 118, Issue 10
J Clin Invest. 2008; 118(10):3411–3419 doi:10.1172/JCI35365
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 3
Frequency, proliferation, and suppressive activity of CD4+CD25highCD127low cells from MS patients and healthy controls.

(A) Percentages of CD25highCD127low cells within the total CD4+ T cell population were determined by flow cytometry analysis of PBMCs. No statistical difference was found between the groups (25 patients and 20 HIs). (B) Regulatory properties of CD4+CD25highCD127low cells were comparable in both HIs (n = 24) and patients (n = 25). (C) Comparison of the proliferation of CD4+CD25highCD127low T cells in MS patients and HIs normalized against the proliferation of the CD4+CD25 T cell subset. The proliferation of CD4+CD25highCD127low T cells was minimal and approaching 0 in both patients and controls. (D) Example in 1 patient of variations of the suppression of proliferation by CD4+CD25highCD127low cells in the cocultures at varying ratios of CD4+CD25highCD127low to CD4+CD25. Decreasing the number of CD4+CD25highCD127low T cells resulted in less suppressor activity. (E) CD4+CD25highCD127low T cells from 1 patient with MS inhibited proliferation of responder T cells isolated from either the autologous individual or the healthy control. Conversely, Tregs from 1 HI were cocultured with responder T cells from the same subject or those from the MS patient. MS#19, MS patient 19; HI#18, HI subject 18. (F) Intracellular FOXP3 staining was performed on CD4+CD25highCD127low T cells in 10 patients and 9 HIs. In A, B, and F, mean values are indicated by horizontal lines.